AstraZeneca C.E.O. to Step Down
Friday, April 27, 2012 - 03:40
in Mathematics & Economics
David Brennan is leaving as the big British pharmaceutical company struggles with generic competition and lower revenue and profits.
David Brennan is leaving as the big British pharmaceutical company struggles with generic competition and lower revenue and profits.